Search
Somatotropin
go.drugbank.com/drugs/DB00052ApprovedInvestigational[A228183, L31508] Synthesized in a strain of _Escherichia coli_, recombinant HGH is a polypeptide hormone that contains 191 amino acid residues with a molecular weight of 22 kDa. … [A228188] Recombinant growth hormone is available as a subcutaneous injection for children and adults under a wide variety of brand names.
Mixtures: Nutropin - Kit Pws(5mg) & Liq(10ml) Im ScCategories: P-glycoprotein substrates, Cytochrome P-450 CYP1A2 InducersDesomorphine
go.drugbank.com/drugs/DB01531ExperimentalIllicitSynonyms: 4,5-epoxy-3-hydroxy-n-methylmorphinan, Deoxydihydromorphine DCategories: Heterocyclic Compounds with 4 or More Rings, Cytochrome P-450 SubstratesTriamcinolone
go.drugbank.com/drugs/DB00620ApprovedInvestigationalVet approved[L8246,L8249,L8252,L8255,L8258,L8261,L8264] Triamcinolone was granted FDA approval on 3 December 1957. … [L8255] Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain,[L8264] or first line as a topical treatment of corticosteroid responsive dermatoses.
Synonyms: 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, 11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dioneInternational brands: Omcilon-ARepaglinide
go.drugbank.com/drugs/DB00912ApprovedInvestigationalApproximately 90% of a single orally administered dose is eliminated in feces and 8% in urine. … Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight.
Mixtures: REPAMEF 2/1000 MG EFERVESAN TABLET, 30 ADET, REPAMEF 2/500 MG EFERVESAN TABLET, 30 ADETCategories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingTramadol
go.drugbank.com/drugs/DB00193ApprovedInvestigationalinto active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits … It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of [morphine].
Mixtures: DOR-2®, Skudexa 75 mg/25 mg FilmtablettenCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesdATP
go.drugbank.com/drugs/DB03222ExperimentalSynonyms: 2'-Deoxyadenosine 5'-triphosphate, Deoxyadenosine 5'-triphosphateCategories: Heterocyclic Compounds, 2-RingEmetonium iodide
go.drugbank.com/drugs/DB13769ExperimentalSynonyms: (2-benzhydryloxyethyl)diethyl-methylammonium iodideCategories: (2-benzhydryloxyethyl)diethyl-methylammonium iodideBBV152
go.drugbank.com/drugs/DB15847InvestigationalThe candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) … Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in humans (NCT04471519).
Synonyms: Whole-Virion Inactivated SARS-CoV-2 VaccineBrexpiprazole
go.drugbank.com/drugs/DB09128ApprovedInvestigationalIt has a high affinity for serotonin, dopamine and alpha (α)-adrenergic receptors. … It also displays stronger antagonism at the 5-HT1A and 5-HT2A receptors.[A182186, A38385, A259661] Brexpiprazole was first approved by the FDA on July 10, 2015.
Categories: MATE 2 Inhibitors, Heterocyclic Compounds, 2-RingProducts: REXULTI (BREXPIPRAZOLE) TABLETS 2 MG, REXULTI (BREXPIPRAZOLE) TABLETS 3 MGTirzepatide
go.drugbank.com/drugs/DB15171ApprovedInvestigational[A246265] Tirzepatide was approved by the FDA on May 13, 2022, under the brand name MOUNJARO by the FDA for the treatment of adults with type 2 diabetes, making it the first and only GIP and GLP-1 receptor … [A246260] Tirzepatide comprises a 39 amino acid linear synthetic peptide conjugated to a C20 fatty diacid moiety.
Categories: Receptors, G-Protein-Coupled, GLP-1 AgonistsProducts: Mounjaro 5 mg/0,5 ml Enjeksiyonluk Çözelti, 4 ADET, Mounjaro 2,5 mg/0,5 ml Enjeksiyonluk Çözelti, 4 ADET